Common Contracts
2 similar License Agreement contracts by Lexeo Therapeutics, Inc.
ContractLicense Agreement • May 5th, 2022 • Lexeo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
[ *** ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.
SECOND LICENSE AGREEMENT BETWEEN LEXEO THERAPEUTICS, LLC AND CORNELL UNIVERSITY FOR DOCKET NO. D-6749 DOCKET NO. D-7225 DOCKET NO. D-7605 DOCKET NO. D-9179 DOCKET NO. D-9325 DOCKET NO. D-9332 DOCKET NO. D-9472 CTL CONTRACT NO. [***]License Agreement • May 5th, 2022 • Lexeo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Second License Agreement (this “Agreement”) is made by and between LEXEO Therapeutics, LLC, a Delaware limited liability company, having an office at 430 East 29th Street, 14th Floor, New York, NY 10016 (“LICENSEE”), and Cornell University, a New York education corporation (“Cornell”), as represented by its Cornell Center for Technology Licensing (“CTL”) at 395 Pine Tree Road, Suite 310, Ithaca, NY 14850. Cornell and LICENSEE each may be referred to herein as a “Party” and together as the “Parties.”
